Join The Jackson Laboratory on the week of June 21st to explore the antibody development pipeline.
In these sessions, you will:
- Explore the many challenges and solutions in the preclinical drug development pipeline
- Learn how to choose the most translationally-relevant preclinical in vivo models to identify promising therapeutic candidates
- Understand how large biopharmaceutical companies use humanized in vivo models as tools to de-risk their antibody drug development pipeline
JAX events are complimentary.
No fees will be charged for registering.
When registering, please use an institutional (e.g. work, university, etc.) email address or contact
our event staff to request an exception. Thank you.
